nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—head and neck cancer—thyroid cancer	0.306	0.619	CtDrD
Docetaxel—lung cancer—thyroid cancer	0.188	0.381	CtDrD
Docetaxel—EGFR—Vandetanib—thyroid cancer	0.117	0.371	CbGbCtD
Docetaxel—ABCC1—Vandetanib—thyroid cancer	0.0288	0.0914	CbGbCtD
Docetaxel—ABCC10—Doxorubicin—thyroid cancer	0.0272	0.0866	CbGbCtD
Docetaxel—ABCC1—Epirubicin—thyroid cancer	0.0198	0.0629	CbGbCtD
Docetaxel—ABCG2—Vandetanib—thyroid cancer	0.0192	0.0612	CbGbCtD
Docetaxel—CYP1B1—Doxorubicin—thyroid cancer	0.0148	0.0471	CbGbCtD
Docetaxel—ABCC2—Sorafenib—thyroid cancer	0.0128	0.0408	CbGbCtD
Docetaxel—ABCG2—Sorafenib—thyroid cancer	0.0116	0.0369	CbGbCtD
Docetaxel—ABCC1—Doxorubicin—thyroid cancer	0.0105	0.0334	CbGbCtD
Docetaxel—CYP3A7—Sorafenib—thyroid cancer	0.00857	0.0272	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.00857	0.0272	CbGbCtD
Docetaxel—ABCC2—Doxorubicin—thyroid cancer	0.00778	0.0247	CbGbCtD
Docetaxel—ABCG2—Doxorubicin—thyroid cancer	0.00704	0.0224	CbGbCtD
Docetaxel—CYP3A5—Sorafenib—thyroid cancer	0.00643	0.0204	CbGbCtD
Docetaxel—ABCB1—Sorafenib—thyroid cancer	0.00418	0.0133	CbGbCtD
Docetaxel—CYP3A4—Vandetanib—thyroid cancer	0.00416	0.0132	CbGbCtD
Docetaxel—ABCB1—Doxorubicin—thyroid cancer	0.00254	0.00807	CbGbCtD
Docetaxel—CYP3A4—Sorafenib—thyroid cancer	0.00251	0.00797	CbGbCtD
Docetaxel—GHRHR—head—thyroid cancer	0.00156	0.0496	CbGeAlD
Docetaxel—CYP3A4—Doxorubicin—thyroid cancer	0.00152	0.00483	CbGbCtD
Docetaxel—BCL2—neck—thyroid cancer	0.00131	0.0418	CbGeAlD
Docetaxel—MAP2—neck—thyroid cancer	0.00114	0.0362	CbGeAlD
Docetaxel—TUBB3—Afatinib—Vandetanib—thyroid cancer	0.000962	0.417	CbGdCrCtD
Docetaxel—NR1I2—head—thyroid cancer	0.000932	0.0297	CbGeAlD
Docetaxel—KIF11—lymph node—thyroid cancer	0.000926	0.0295	CbGeAlD
Docetaxel—TUBB8—head—thyroid cancer	0.000893	0.0285	CbGeAlD
Docetaxel—MAP2—saliva-secreting gland—thyroid cancer	0.000887	0.0283	CbGeAlD
Docetaxel—MAPT—thyroid gland—thyroid cancer	0.000874	0.0279	CbGeAlD
Docetaxel—MAP4—thyroid gland—thyroid cancer	0.000687	0.0219	CbGeAlD
Docetaxel—MAP2—trachea—thyroid cancer	0.000684	0.0218	CbGeAlD
Docetaxel—TUBB2B—saliva-secreting gland—thyroid cancer	0.000662	0.0211	CbGeAlD
Docetaxel—TUBB—saliva-secreting gland—thyroid cancer	0.000627	0.02	CbGeAlD
Docetaxel—BCL2—thyroid gland—thyroid cancer	0.000625	0.0199	CbGeAlD
Docetaxel—TUBB2A—saliva-secreting gland—thyroid cancer	0.000623	0.0199	CbGeAlD
Docetaxel—EGFR—thyroid gland—thyroid cancer	0.000617	0.0197	CbGeAlD
Docetaxel—TUBB6—saliva-secreting gland—thyroid cancer	0.000615	0.0196	CbGeAlD
Docetaxel—TUBB3—head—thyroid cancer	0.00061	0.0194	CbGeAlD
Docetaxel—MAP4—head—thyroid cancer	0.00061	0.0194	CbGeAlD
Docetaxel—TUBB1—head—thyroid cancer	0.000596	0.019	CbGeAlD
Docetaxel—TUBB4B—Afatinib—Vandetanib—thyroid cancer	0.000595	0.258	CbGdCrCtD
Docetaxel—BCL2—head—thyroid cancer	0.000554	0.0177	CbGeAlD
Docetaxel—MAPT—lymph node—thyroid cancer	0.000543	0.0173	CbGeAlD
Docetaxel—MAP2—thyroid gland—thyroid cancer	0.000541	0.0172	CbGeAlD
Docetaxel—ABCC10—saliva-secreting gland—thyroid cancer	0.000538	0.0172	CbGeAlD
Docetaxel—TUBB4B—saliva-secreting gland—thyroid cancer	0.000534	0.017	CbGeAlD
Docetaxel—TUBB2B—trachea—thyroid cancer	0.000511	0.0163	CbGeAlD
Docetaxel—TUBB—trachea—thyroid cancer	0.000483	0.0154	CbGeAlD
Docetaxel—TUBB2A—trachea—thyroid cancer	0.000481	0.0153	CbGeAlD
Docetaxel—MAP2—head—thyroid cancer	0.00048	0.0153	CbGeAlD
Docetaxel—TUBB6—trachea—thyroid cancer	0.000474	0.0151	CbGeAlD
Docetaxel—TUBB6—Erlotinib—Vandetanib—thyroid cancer	0.000453	0.196	CbGdCrCtD
Docetaxel—MAP4—lymph node—thyroid cancer	0.000427	0.0136	CbGeAlD
Docetaxel—TUBB4A—thyroid gland—thyroid cancer	0.000418	0.0133	CbGeAlD
Docetaxel—ABCC10—trachea—thyroid cancer	0.000415	0.0132	CbGeAlD
Docetaxel—TUBB4B—trachea—thyroid cancer	0.000412	0.0131	CbGeAlD
Docetaxel—TUBB2B—thyroid gland—thyroid cancer	0.000404	0.0129	CbGeAlD
Docetaxel—BCL2—lymph node—thyroid cancer	0.000388	0.0124	CbGeAlD
Docetaxel—EGFR—lymph node—thyroid cancer	0.000383	0.0122	CbGeAlD
Docetaxel—TUBB—thyroid gland—thyroid cancer	0.000382	0.0122	CbGeAlD
Docetaxel—TUBB2A—thyroid gland—thyroid cancer	0.00038	0.0121	CbGeAlD
Docetaxel—TUBB6—thyroid gland—thyroid cancer	0.000375	0.012	CbGeAlD
Docetaxel—TUBB4A—head—thyroid cancer	0.000371	0.0118	CbGeAlD
Docetaxel—TUBB2B—head—thyroid cancer	0.000359	0.0114	CbGeAlD
Docetaxel—TUBB2A—head—thyroid cancer	0.000337	0.0108	CbGeAlD
Docetaxel—MAP2—lymph node—thyroid cancer	0.000336	0.0107	CbGeAlD
Docetaxel—TUBB6—head—thyroid cancer	0.000333	0.0106	CbGeAlD
Docetaxel—ABCC10—thyroid gland—thyroid cancer	0.000328	0.0105	CbGeAlD
Docetaxel—TUBB4B—thyroid gland—thyroid cancer	0.000326	0.0104	CbGeAlD
Docetaxel—ABCG2—saliva-secreting gland—thyroid cancer	0.000315	0.01	CbGeAlD
Docetaxel—TUBB6—Afatinib—Vandetanib—thyroid cancer	0.000296	0.128	CbGdCrCtD
Docetaxel—ABCC1—trachea—thyroid cancer	0.000294	0.00936	CbGeAlD
Docetaxel—TUBB4B—head—thyroid cancer	0.000289	0.00922	CbGeAlD
Docetaxel—TUBB4A—lymph node—thyroid cancer	0.00026	0.00828	CbGeAlD
Docetaxel—CYP1B1—thyroid gland—thyroid cancer	0.000258	0.00823	CbGeAlD
Docetaxel—TUBB2B—lymph node—thyroid cancer	0.000251	0.008	CbGeAlD
Docetaxel—TUBB—lymph node—thyroid cancer	0.000238	0.00757	CbGeAlD
Docetaxel—TUBB2A—lymph node—thyroid cancer	0.000236	0.00753	CbGeAlD
Docetaxel—TUBB6—lymph node—thyroid cancer	0.000233	0.00743	CbGeAlD
Docetaxel—ABCC1—thyroid gland—thyroid cancer	0.000232	0.00741	CbGeAlD
Docetaxel—CYP1B1—head—thyroid cancer	0.000229	0.00731	CbGeAlD
Docetaxel—ABCC10—lymph node—thyroid cancer	0.000204	0.00651	CbGeAlD
Docetaxel—TUBB4B—lymph node—thyroid cancer	0.000203	0.00646	CbGeAlD
Docetaxel—ABCG2—thyroid gland—thyroid cancer	0.000192	0.00613	CbGeAlD
Docetaxel—ABCC2—lymph node—thyroid cancer	0.000164	0.00522	CbGeAlD
Docetaxel—CYP1B1—lymph node—thyroid cancer	0.00016	0.00512	CbGeAlD
Docetaxel—ABCC1—lymph node—thyroid cancer	0.000144	0.0046	CbGeAlD
Docetaxel—ABCB1—trachea—thyroid cancer	0.00012	0.00382	CbGeAlD
Docetaxel—ABCG2—lymph node—thyroid cancer	0.000119	0.00381	CbGeAlD
Docetaxel—ABCB1—thyroid gland—thyroid cancer	9.48e-05	0.00302	CbGeAlD
Docetaxel—ABCB1—head—thyroid cancer	8.41e-05	0.00268	CbGeAlD
Docetaxel—Sepsis—Doxorubicin—thyroid cancer	8.09e-05	0.000808	CcSEcCtD
Docetaxel—Cardiac failure congestive—Epirubicin—thyroid cancer	8.07e-05	0.000806	CcSEcCtD
Docetaxel—Gastrointestinal pain—Sorafenib—thyroid cancer	7.95e-05	0.000795	CcSEcCtD
Docetaxel—Phlebitis—Doxorubicin—thyroid cancer	7.86e-05	0.000785	CcSEcCtD
Docetaxel—Hot flush—Epirubicin—thyroid cancer	7.82e-05	0.000781	CcSEcCtD
Docetaxel—Thrombophlebitis—Doxorubicin—thyroid cancer	7.82e-05	0.000781	CcSEcCtD
Docetaxel—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	7.78e-05	0.000777	CcSEcCtD
Docetaxel—Menopausal symptoms—Epirubicin—thyroid cancer	7.75e-05	0.000775	CcSEcCtD
Docetaxel—Body temperature increased—Sorafenib—thyroid cancer	7.69e-05	0.000768	CcSEcCtD
Docetaxel—Abdominal pain—Sorafenib—thyroid cancer	7.69e-05	0.000768	CcSEcCtD
Docetaxel—Renal impairment—Epirubicin—thyroid cancer	7.69e-05	0.000768	CcSEcCtD
Docetaxel—Dermatitis bullous—Epirubicin—thyroid cancer	7.65e-05	0.000765	CcSEcCtD
Docetaxel—Hepatic failure—Doxorubicin—thyroid cancer	7.53e-05	0.000752	CcSEcCtD
Docetaxel—Cardiac failure—Epirubicin—thyroid cancer	7.49e-05	0.000749	CcSEcCtD
Docetaxel—Lethargy—Epirubicin—thyroid cancer	7.46e-05	0.000746	CcSEcCtD
Docetaxel—Cardiac failure congestive—Doxorubicin—thyroid cancer	7.46e-05	0.000746	CcSEcCtD
Docetaxel—Hyponatraemia—Epirubicin—thyroid cancer	7.34e-05	0.000734	CcSEcCtD
Docetaxel—Pain in extremity—Epirubicin—thyroid cancer	7.31e-05	0.000731	CcSEcCtD
Docetaxel—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	7.31e-05	0.000731	CcSEcCtD
Docetaxel—Hot flush—Doxorubicin—thyroid cancer	7.23e-05	0.000723	CcSEcCtD
Docetaxel—Migraine—Epirubicin—thyroid cancer	7.2e-05	0.000719	CcSEcCtD
Docetaxel—Menopausal symptoms—Doxorubicin—thyroid cancer	7.17e-05	0.000717	CcSEcCtD
Docetaxel—Hypersensitivity—Sorafenib—thyroid cancer	7.17e-05	0.000716	CcSEcCtD
Docetaxel—Renal impairment—Doxorubicin—thyroid cancer	7.11e-05	0.000711	CcSEcCtD
Docetaxel—Dermatitis bullous—Doxorubicin—thyroid cancer	7.08e-05	0.000708	CcSEcCtD
Docetaxel—Asthenia—Sorafenib—thyroid cancer	6.98e-05	0.000697	CcSEcCtD
Docetaxel—Cardiac failure—Doxorubicin—thyroid cancer	6.93e-05	0.000693	CcSEcCtD
Docetaxel—Lethargy—Doxorubicin—thyroid cancer	6.91e-05	0.00069	CcSEcCtD
Docetaxel—Pruritus—Sorafenib—thyroid cancer	6.88e-05	0.000688	CcSEcCtD
Docetaxel—Ataxia—Epirubicin—thyroid cancer	6.88e-05	0.000687	CcSEcCtD
Docetaxel—Dehydration—Epirubicin—thyroid cancer	6.8e-05	0.00068	CcSEcCtD
Docetaxel—Hyponatraemia—Doxorubicin—thyroid cancer	6.8e-05	0.000679	CcSEcCtD
Docetaxel—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	6.77e-05	0.000676	CcSEcCtD
Docetaxel—Pain in extremity—Doxorubicin—thyroid cancer	6.77e-05	0.000676	CcSEcCtD
Docetaxel—Liver function test abnormal—Epirubicin—thyroid cancer	6.75e-05	0.000675	CcSEcCtD
Docetaxel—Dry skin—Epirubicin—thyroid cancer	6.7e-05	0.00067	CcSEcCtD
Docetaxel—Orthostatic hypotension—Epirubicin—thyroid cancer	6.68e-05	0.000667	CcSEcCtD
Docetaxel—Abdominal pain upper—Epirubicin—thyroid cancer	6.68e-05	0.000667	CcSEcCtD
Docetaxel—Migraine—Doxorubicin—thyroid cancer	6.66e-05	0.000666	CcSEcCtD
Docetaxel—Diarrhoea—Sorafenib—thyroid cancer	6.66e-05	0.000665	CcSEcCtD
Docetaxel—Breast disorder—Epirubicin—thyroid cancer	6.61e-05	0.00066	CcSEcCtD
Docetaxel—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	6.59e-05	0.000658	CcSEcCtD
Docetaxel—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	6.59e-05	0.000658	CcSEcCtD
Docetaxel—Nasopharyngitis—Epirubicin—thyroid cancer	6.54e-05	0.000654	CcSEcCtD
Docetaxel—Alanine aminotransferase increased—Epirubicin—thyroid cancer	6.45e-05	0.000645	CcSEcCtD
Docetaxel—Dizziness—Sorafenib—thyroid cancer	6.43e-05	0.000643	CcSEcCtD
Docetaxel—Ataxia—Doxorubicin—thyroid cancer	6.36e-05	0.000636	CcSEcCtD
Docetaxel—Dysphagia—Epirubicin—thyroid cancer	6.32e-05	0.000632	CcSEcCtD
Docetaxel—Dehydration—Doxorubicin—thyroid cancer	6.29e-05	0.000629	CcSEcCtD
Docetaxel—Liver function test abnormal—Doxorubicin—thyroid cancer	6.25e-05	0.000624	CcSEcCtD
Docetaxel—Dry skin—Doxorubicin—thyroid cancer	6.2e-05	0.00062	CcSEcCtD
Docetaxel—Vomiting—Sorafenib—thyroid cancer	6.18e-05	0.000618	CcSEcCtD
Docetaxel—Orthostatic hypotension—Doxorubicin—thyroid cancer	6.18e-05	0.000618	CcSEcCtD
Docetaxel—Abdominal pain upper—Doxorubicin—thyroid cancer	6.18e-05	0.000618	CcSEcCtD
Docetaxel—Angina pectoris—Epirubicin—thyroid cancer	6.16e-05	0.000615	CcSEcCtD
Docetaxel—Rash—Sorafenib—thyroid cancer	6.13e-05	0.000613	CcSEcCtD
Docetaxel—Dermatitis—Sorafenib—thyroid cancer	6.13e-05	0.000612	CcSEcCtD
Docetaxel—Breast disorder—Doxorubicin—thyroid cancer	6.12e-05	0.000611	CcSEcCtD
Docetaxel—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	6.09e-05	0.000609	CcSEcCtD
Docetaxel—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	6.09e-05	0.000609	CcSEcCtD
Docetaxel—Headache—Sorafenib—thyroid cancer	6.09e-05	0.000609	CcSEcCtD
Docetaxel—Nasopharyngitis—Doxorubicin—thyroid cancer	6.05e-05	0.000605	CcSEcCtD
Docetaxel—Pancytopenia—Epirubicin—thyroid cancer	6e-05	0.0006	CcSEcCtD
Docetaxel—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	5.97e-05	0.000596	CcSEcCtD
Docetaxel—Neutropenia—Epirubicin—thyroid cancer	5.91e-05	0.000591	CcSEcCtD
Docetaxel—ABCB1—lymph node—thyroid cancer	5.89e-05	0.00188	CbGeAlD
Docetaxel—Dysphagia—Doxorubicin—thyroid cancer	5.85e-05	0.000584	CcSEcCtD
Docetaxel—Nausea—Sorafenib—thyroid cancer	5.78e-05	0.000577	CcSEcCtD
Docetaxel—Weight increased—Epirubicin—thyroid cancer	5.75e-05	0.000575	CcSEcCtD
Docetaxel—Weight decreased—Epirubicin—thyroid cancer	5.72e-05	0.000571	CcSEcCtD
Docetaxel—Angina pectoris—Doxorubicin—thyroid cancer	5.7e-05	0.000569	CcSEcCtD
Docetaxel—Pneumonia—Epirubicin—thyroid cancer	5.67e-05	0.000566	CcSEcCtD
Docetaxel—Infestation NOS—Epirubicin—thyroid cancer	5.64e-05	0.000563	CcSEcCtD
Docetaxel—Infestation—Epirubicin—thyroid cancer	5.64e-05	0.000563	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	5.59e-05	0.000558	CcSEcCtD
Docetaxel—Pancytopenia—Doxorubicin—thyroid cancer	5.55e-05	0.000555	CcSEcCtD
Docetaxel—Renal failure—Epirubicin—thyroid cancer	5.54e-05	0.000554	CcSEcCtD
Docetaxel—Neuropathy peripheral—Epirubicin—thyroid cancer	5.53e-05	0.000552	CcSEcCtD
Docetaxel—Stomatitis—Epirubicin—thyroid cancer	5.49e-05	0.000549	CcSEcCtD
Docetaxel—Jaundice—Epirubicin—thyroid cancer	5.49e-05	0.000549	CcSEcCtD
Docetaxel—Conjunctivitis—Epirubicin—thyroid cancer	5.48e-05	0.000547	CcSEcCtD
Docetaxel—Neutropenia—Doxorubicin—thyroid cancer	5.47e-05	0.000547	CcSEcCtD
Docetaxel—Hepatobiliary disease—Epirubicin—thyroid cancer	5.33e-05	0.000533	CcSEcCtD
Docetaxel—Weight increased—Doxorubicin—thyroid cancer	5.32e-05	0.000532	CcSEcCtD
Docetaxel—Epistaxis—Epirubicin—thyroid cancer	5.32e-05	0.000531	CcSEcCtD
Docetaxel—Weight decreased—Doxorubicin—thyroid cancer	5.29e-05	0.000529	CcSEcCtD
Docetaxel—Agranulocytosis—Epirubicin—thyroid cancer	5.26e-05	0.000526	CcSEcCtD
Docetaxel—Pneumonia—Doxorubicin—thyroid cancer	5.25e-05	0.000524	CcSEcCtD
Docetaxel—Infestation NOS—Doxorubicin—thyroid cancer	5.22e-05	0.000521	CcSEcCtD
Docetaxel—Infestation—Doxorubicin—thyroid cancer	5.22e-05	0.000521	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	5.17e-05	0.000517	CcSEcCtD
Docetaxel—Renal failure—Doxorubicin—thyroid cancer	5.13e-05	0.000512	CcSEcCtD
Docetaxel—Neuropathy peripheral—Doxorubicin—thyroid cancer	5.11e-05	0.000511	CcSEcCtD
Docetaxel—Haemoglobin—Epirubicin—thyroid cancer	5.09e-05	0.000508	CcSEcCtD
Docetaxel—Stomatitis—Doxorubicin—thyroid cancer	5.08e-05	0.000508	CcSEcCtD
Docetaxel—Jaundice—Doxorubicin—thyroid cancer	5.08e-05	0.000508	CcSEcCtD
Docetaxel—Rhinitis—Epirubicin—thyroid cancer	5.07e-05	0.000507	CcSEcCtD
Docetaxel—Conjunctivitis—Doxorubicin—thyroid cancer	5.07e-05	0.000507	CcSEcCtD
Docetaxel—Haemorrhage—Epirubicin—thyroid cancer	5.06e-05	0.000506	CcSEcCtD
Docetaxel—Hepatitis—Epirubicin—thyroid cancer	5.06e-05	0.000506	CcSEcCtD
Docetaxel—Hypoaesthesia—Epirubicin—thyroid cancer	5.03e-05	0.000503	CcSEcCtD
Docetaxel—Pharyngitis—Epirubicin—thyroid cancer	5.02e-05	0.000502	CcSEcCtD
Docetaxel—Urinary tract disorder—Epirubicin—thyroid cancer	5e-05	0.000499	CcSEcCtD
Docetaxel—Oedema peripheral—Epirubicin—thyroid cancer	4.98e-05	0.000498	CcSEcCtD
Docetaxel—Connective tissue disorder—Epirubicin—thyroid cancer	4.97e-05	0.000497	CcSEcCtD
Docetaxel—Urethral disorder—Epirubicin—thyroid cancer	4.96e-05	0.000496	CcSEcCtD
Docetaxel—Hepatobiliary disease—Doxorubicin—thyroid cancer	4.93e-05	0.000493	CcSEcCtD
Docetaxel—Epistaxis—Doxorubicin—thyroid cancer	4.92e-05	0.000492	CcSEcCtD
Docetaxel—Visual impairment—Epirubicin—thyroid cancer	4.88e-05	0.000487	CcSEcCtD
Docetaxel—Agranulocytosis—Doxorubicin—thyroid cancer	4.87e-05	0.000486	CcSEcCtD
Docetaxel—Erythema multiforme—Epirubicin—thyroid cancer	4.78e-05	0.000478	CcSEcCtD
Docetaxel—Eye disorder—Epirubicin—thyroid cancer	4.73e-05	0.000472	CcSEcCtD
Docetaxel—Haemoglobin—Doxorubicin—thyroid cancer	4.71e-05	0.00047	CcSEcCtD
Docetaxel—Cardiac disorder—Epirubicin—thyroid cancer	4.7e-05	0.000469	CcSEcCtD
Docetaxel—Flushing—Epirubicin—thyroid cancer	4.7e-05	0.000469	CcSEcCtD
Docetaxel—Rhinitis—Doxorubicin—thyroid cancer	4.69e-05	0.000469	CcSEcCtD
Docetaxel—Haemorrhage—Doxorubicin—thyroid cancer	4.68e-05	0.000468	CcSEcCtD
Docetaxel—Hepatitis—Doxorubicin—thyroid cancer	4.68e-05	0.000468	CcSEcCtD
Docetaxel—Hypoaesthesia—Doxorubicin—thyroid cancer	4.66e-05	0.000465	CcSEcCtD
Docetaxel—Pharyngitis—Doxorubicin—thyroid cancer	4.65e-05	0.000464	CcSEcCtD
Docetaxel—Urinary tract disorder—Doxorubicin—thyroid cancer	4.62e-05	0.000462	CcSEcCtD
Docetaxel—Oedema peripheral—Doxorubicin—thyroid cancer	4.61e-05	0.000461	CcSEcCtD
Docetaxel—Connective tissue disorder—Doxorubicin—thyroid cancer	4.6e-05	0.00046	CcSEcCtD
Docetaxel—Angiopathy—Epirubicin—thyroid cancer	4.59e-05	0.000459	CcSEcCtD
Docetaxel—Urethral disorder—Doxorubicin—thyroid cancer	4.59e-05	0.000459	CcSEcCtD
Docetaxel—Immune system disorder—Epirubicin—thyroid cancer	4.57e-05	0.000457	CcSEcCtD
Docetaxel—Mediastinal disorder—Epirubicin—thyroid cancer	4.56e-05	0.000456	CcSEcCtD
Docetaxel—Chills—Epirubicin—thyroid cancer	4.54e-05	0.000454	CcSEcCtD
Docetaxel—Arrhythmia—Epirubicin—thyroid cancer	4.52e-05	0.000452	CcSEcCtD
Docetaxel—Visual impairment—Doxorubicin—thyroid cancer	4.51e-05	0.000451	CcSEcCtD
Docetaxel—Alopecia—Epirubicin—thyroid cancer	4.47e-05	0.000447	CcSEcCtD
Docetaxel—Mental disorder—Epirubicin—thyroid cancer	4.43e-05	0.000443	CcSEcCtD
Docetaxel—Erythema multiforme—Doxorubicin—thyroid cancer	4.43e-05	0.000442	CcSEcCtD
Docetaxel—Erythema—Epirubicin—thyroid cancer	4.4e-05	0.00044	CcSEcCtD
Docetaxel—Malnutrition—Epirubicin—thyroid cancer	4.4e-05	0.00044	CcSEcCtD
Docetaxel—Eye disorder—Doxorubicin—thyroid cancer	4.38e-05	0.000437	CcSEcCtD
Docetaxel—Cardiac disorder—Doxorubicin—thyroid cancer	4.35e-05	0.000434	CcSEcCtD
Docetaxel—Flushing—Doxorubicin—thyroid cancer	4.35e-05	0.000434	CcSEcCtD
Docetaxel—Dysgeusia—Epirubicin—thyroid cancer	4.31e-05	0.000431	CcSEcCtD
Docetaxel—Back pain—Epirubicin—thyroid cancer	4.26e-05	0.000426	CcSEcCtD
Docetaxel—Angiopathy—Doxorubicin—thyroid cancer	4.25e-05	0.000424	CcSEcCtD
Docetaxel—Muscle spasms—Epirubicin—thyroid cancer	4.23e-05	0.000423	CcSEcCtD
Docetaxel—Immune system disorder—Doxorubicin—thyroid cancer	4.23e-05	0.000423	CcSEcCtD
Docetaxel—Mediastinal disorder—Doxorubicin—thyroid cancer	4.22e-05	0.000422	CcSEcCtD
Docetaxel—Chills—Doxorubicin—thyroid cancer	4.2e-05	0.00042	CcSEcCtD
Docetaxel—Arrhythmia—Doxorubicin—thyroid cancer	4.18e-05	0.000418	CcSEcCtD
Docetaxel—Alopecia—Doxorubicin—thyroid cancer	4.14e-05	0.000413	CcSEcCtD
Docetaxel—Mental disorder—Doxorubicin—thyroid cancer	4.1e-05	0.00041	CcSEcCtD
Docetaxel—Erythema—Doxorubicin—thyroid cancer	4.08e-05	0.000407	CcSEcCtD
Docetaxel—Malnutrition—Doxorubicin—thyroid cancer	4.08e-05	0.000407	CcSEcCtD
Docetaxel—Anaemia—Epirubicin—thyroid cancer	4.07e-05	0.000407	CcSEcCtD
Docetaxel—Dysgeusia—Doxorubicin—thyroid cancer	3.99e-05	0.000399	CcSEcCtD
Docetaxel—Syncope—Epirubicin—thyroid cancer	3.95e-05	0.000395	CcSEcCtD
Docetaxel—Leukopenia—Epirubicin—thyroid cancer	3.94e-05	0.000394	CcSEcCtD
Docetaxel—Back pain—Doxorubicin—thyroid cancer	3.94e-05	0.000394	CcSEcCtD
Docetaxel—Muscle spasms—Doxorubicin—thyroid cancer	3.92e-05	0.000392	CcSEcCtD
Docetaxel—Palpitations—Epirubicin—thyroid cancer	3.89e-05	0.000389	CcSEcCtD
Docetaxel—Loss of consciousness—Epirubicin—thyroid cancer	3.87e-05	0.000387	CcSEcCtD
Docetaxel—Cough—Epirubicin—thyroid cancer	3.84e-05	0.000384	CcSEcCtD
Docetaxel—Convulsion—Epirubicin—thyroid cancer	3.82e-05	0.000381	CcSEcCtD
Docetaxel—Hypertension—Epirubicin—thyroid cancer	3.8e-05	0.00038	CcSEcCtD
Docetaxel—Anaemia—Doxorubicin—thyroid cancer	3.77e-05	0.000376	CcSEcCtD
Docetaxel—Chest pain—Epirubicin—thyroid cancer	3.75e-05	0.000375	CcSEcCtD
Docetaxel—Myalgia—Epirubicin—thyroid cancer	3.75e-05	0.000375	CcSEcCtD
Docetaxel—Arthralgia—Epirubicin—thyroid cancer	3.75e-05	0.000375	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	3.72e-05	0.000372	CcSEcCtD
Docetaxel—Dry mouth—Epirubicin—thyroid cancer	3.67e-05	0.000366	CcSEcCtD
Docetaxel—Syncope—Doxorubicin—thyroid cancer	3.65e-05	0.000365	CcSEcCtD
Docetaxel—Leukopenia—Doxorubicin—thyroid cancer	3.65e-05	0.000365	CcSEcCtD
Docetaxel—Confusional state—Epirubicin—thyroid cancer	3.62e-05	0.000362	CcSEcCtD
Docetaxel—Palpitations—Doxorubicin—thyroid cancer	3.6e-05	0.00036	CcSEcCtD
Docetaxel—Oedema—Epirubicin—thyroid cancer	3.59e-05	0.000359	CcSEcCtD
Docetaxel—Anaphylactic shock—Epirubicin—thyroid cancer	3.59e-05	0.000359	CcSEcCtD
Docetaxel—Loss of consciousness—Doxorubicin—thyroid cancer	3.58e-05	0.000358	CcSEcCtD
Docetaxel—Infection—Epirubicin—thyroid cancer	3.57e-05	0.000357	CcSEcCtD
Docetaxel—Cough—Doxorubicin—thyroid cancer	3.56e-05	0.000355	CcSEcCtD
Docetaxel—Shock—Epirubicin—thyroid cancer	3.54e-05	0.000353	CcSEcCtD
Docetaxel—Convulsion—Doxorubicin—thyroid cancer	3.53e-05	0.000353	CcSEcCtD
Docetaxel—Nervous system disorder—Epirubicin—thyroid cancer	3.53e-05	0.000352	CcSEcCtD
Docetaxel—Thrombocytopenia—Epirubicin—thyroid cancer	3.52e-05	0.000352	CcSEcCtD
Docetaxel—Hypertension—Doxorubicin—thyroid cancer	3.52e-05	0.000352	CcSEcCtD
Docetaxel—Tachycardia—Epirubicin—thyroid cancer	3.51e-05	0.000351	CcSEcCtD
Docetaxel—Skin disorder—Epirubicin—thyroid cancer	3.49e-05	0.000349	CcSEcCtD
Docetaxel—Chest pain—Doxorubicin—thyroid cancer	3.47e-05	0.000347	CcSEcCtD
Docetaxel—Myalgia—Doxorubicin—thyroid cancer	3.47e-05	0.000347	CcSEcCtD
Docetaxel—Arthralgia—Doxorubicin—thyroid cancer	3.47e-05	0.000347	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	3.45e-05	0.000344	CcSEcCtD
Docetaxel—Anorexia—Epirubicin—thyroid cancer	3.43e-05	0.000342	CcSEcCtD
Docetaxel—Dry mouth—Doxorubicin—thyroid cancer	3.39e-05	0.000339	CcSEcCtD
Docetaxel—Hypotension—Epirubicin—thyroid cancer	3.36e-05	0.000336	CcSEcCtD
Docetaxel—Confusional state—Doxorubicin—thyroid cancer	3.35e-05	0.000335	CcSEcCtD
Docetaxel—Oedema—Doxorubicin—thyroid cancer	3.33e-05	0.000332	CcSEcCtD
Docetaxel—Anaphylactic shock—Doxorubicin—thyroid cancer	3.33e-05	0.000332	CcSEcCtD
Docetaxel—Infection—Doxorubicin—thyroid cancer	3.3e-05	0.00033	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Epirubicin—thyroid cancer	3.28e-05	0.000327	CcSEcCtD
Docetaxel—Shock—Doxorubicin—thyroid cancer	3.27e-05	0.000327	CcSEcCtD
Docetaxel—Nervous system disorder—Doxorubicin—thyroid cancer	3.26e-05	0.000326	CcSEcCtD
Docetaxel—Thrombocytopenia—Doxorubicin—thyroid cancer	3.26e-05	0.000325	CcSEcCtD
Docetaxel—Insomnia—Epirubicin—thyroid cancer	3.25e-05	0.000325	CcSEcCtD
Docetaxel—Tachycardia—Doxorubicin—thyroid cancer	3.25e-05	0.000324	CcSEcCtD
Docetaxel—Skin disorder—Doxorubicin—thyroid cancer	3.23e-05	0.000323	CcSEcCtD
Docetaxel—Paraesthesia—Epirubicin—thyroid cancer	3.23e-05	0.000323	CcSEcCtD
Docetaxel—Dyspnoea—Epirubicin—thyroid cancer	3.21e-05	0.00032	CcSEcCtD
Docetaxel—Somnolence—Epirubicin—thyroid cancer	3.2e-05	0.000319	CcSEcCtD
Docetaxel—Anorexia—Doxorubicin—thyroid cancer	3.17e-05	0.000317	CcSEcCtD
Docetaxel—Dyspepsia—Epirubicin—thyroid cancer	3.16e-05	0.000316	CcSEcCtD
Docetaxel—Decreased appetite—Epirubicin—thyroid cancer	3.13e-05	0.000312	CcSEcCtD
Docetaxel—Hypotension—Doxorubicin—thyroid cancer	3.11e-05	0.000311	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Epirubicin—thyroid cancer	3.1e-05	0.00031	CcSEcCtD
Docetaxel—Fatigue—Epirubicin—thyroid cancer	3.1e-05	0.00031	CcSEcCtD
Docetaxel—Pain—Epirubicin—thyroid cancer	3.07e-05	0.000307	CcSEcCtD
Docetaxel—Constipation—Epirubicin—thyroid cancer	3.07e-05	0.000307	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	3.03e-05	0.000303	CcSEcCtD
Docetaxel—Insomnia—Doxorubicin—thyroid cancer	3.01e-05	0.000301	CcSEcCtD
Docetaxel—Paraesthesia—Doxorubicin—thyroid cancer	2.99e-05	0.000298	CcSEcCtD
Docetaxel—Dyspnoea—Doxorubicin—thyroid cancer	2.97e-05	0.000296	CcSEcCtD
Docetaxel—Feeling abnormal—Epirubicin—thyroid cancer	2.96e-05	0.000296	CcSEcCtD
Docetaxel—Somnolence—Doxorubicin—thyroid cancer	2.96e-05	0.000295	CcSEcCtD
Docetaxel—Gastrointestinal pain—Epirubicin—thyroid cancer	2.94e-05	0.000294	CcSEcCtD
Docetaxel—Dyspepsia—Doxorubicin—thyroid cancer	2.93e-05	0.000293	CcSEcCtD
Docetaxel—Decreased appetite—Doxorubicin—thyroid cancer	2.89e-05	0.000289	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Doxorubicin—thyroid cancer	2.87e-05	0.000287	CcSEcCtD
Docetaxel—Fatigue—Doxorubicin—thyroid cancer	2.87e-05	0.000287	CcSEcCtD
Docetaxel—Pain—Doxorubicin—thyroid cancer	2.84e-05	0.000284	CcSEcCtD
Docetaxel—Constipation—Doxorubicin—thyroid cancer	2.84e-05	0.000284	CcSEcCtD
Docetaxel—Abdominal pain—Epirubicin—thyroid cancer	2.84e-05	0.000284	CcSEcCtD
Docetaxel—Body temperature increased—Epirubicin—thyroid cancer	2.84e-05	0.000284	CcSEcCtD
Docetaxel—Feeling abnormal—Doxorubicin—thyroid cancer	2.74e-05	0.000274	CcSEcCtD
Docetaxel—Gastrointestinal pain—Doxorubicin—thyroid cancer	2.72e-05	0.000272	CcSEcCtD
Docetaxel—Hypersensitivity—Epirubicin—thyroid cancer	2.65e-05	0.000265	CcSEcCtD
Docetaxel—Abdominal pain—Doxorubicin—thyroid cancer	2.63e-05	0.000263	CcSEcCtD
Docetaxel—Body temperature increased—Doxorubicin—thyroid cancer	2.63e-05	0.000263	CcSEcCtD
Docetaxel—Asthenia—Epirubicin—thyroid cancer	2.58e-05	0.000258	CcSEcCtD
Docetaxel—Pruritus—Epirubicin—thyroid cancer	2.54e-05	0.000254	CcSEcCtD
Docetaxel—Diarrhoea—Epirubicin—thyroid cancer	2.46e-05	0.000246	CcSEcCtD
Docetaxel—Hypersensitivity—Doxorubicin—thyroid cancer	2.45e-05	0.000245	CcSEcCtD
Docetaxel—Asthenia—Doxorubicin—thyroid cancer	2.39e-05	0.000238	CcSEcCtD
Docetaxel—Dizziness—Epirubicin—thyroid cancer	2.38e-05	0.000238	CcSEcCtD
Docetaxel—Pruritus—Doxorubicin—thyroid cancer	2.35e-05	0.000235	CcSEcCtD
Docetaxel—Vomiting—Epirubicin—thyroid cancer	2.29e-05	0.000228	CcSEcCtD
Docetaxel—Diarrhoea—Doxorubicin—thyroid cancer	2.28e-05	0.000227	CcSEcCtD
Docetaxel—Rash—Epirubicin—thyroid cancer	2.27e-05	0.000226	CcSEcCtD
Docetaxel—Dermatitis—Epirubicin—thyroid cancer	2.26e-05	0.000226	CcSEcCtD
Docetaxel—Headache—Epirubicin—thyroid cancer	2.25e-05	0.000225	CcSEcCtD
Docetaxel—Dizziness—Doxorubicin—thyroid cancer	2.2e-05	0.00022	CcSEcCtD
Docetaxel—Nausea—Epirubicin—thyroid cancer	2.14e-05	0.000213	CcSEcCtD
Docetaxel—Vomiting—Doxorubicin—thyroid cancer	2.11e-05	0.000211	CcSEcCtD
Docetaxel—Rash—Doxorubicin—thyroid cancer	2.1e-05	0.00021	CcSEcCtD
Docetaxel—Dermatitis—Doxorubicin—thyroid cancer	2.1e-05	0.000209	CcSEcCtD
Docetaxel—Headache—Doxorubicin—thyroid cancer	2.08e-05	0.000208	CcSEcCtD
Docetaxel—Nausea—Doxorubicin—thyroid cancer	1.98e-05	0.000197	CcSEcCtD
Docetaxel—EGFR—Signaling by FGFR in disease—KRAS—thyroid cancer	1.23e-05	0.000212	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—KRAS—thyroid cancer	1.23e-05	0.000212	CbGpPWpGaD
Docetaxel—EGFR—Disease—TPR—thyroid cancer	1.23e-05	0.000212	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—CCND1—thyroid cancer	1.23e-05	0.000211	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MEN1—thyroid cancer	1.23e-05	0.000211	CbGpPWpGaD
Docetaxel—BCL2—Immune System—NRG1—thyroid cancer	1.23e-05	0.000211	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	1.23e-05	0.000211	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—KRAS—thyroid cancer	1.22e-05	0.00021	CbGpPWpGaD
Docetaxel—EGFR—Disease—PRKAR1A—thyroid cancer	1.21e-05	0.000208	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—KRAS—thyroid cancer	1.21e-05	0.000208	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—KRAS—thyroid cancer	1.21e-05	0.000207	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—HRAS—thyroid cancer	1.2e-05	0.000207	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—HPGD—thyroid cancer	1.2e-05	0.000206	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—NRG1—thyroid cancer	1.2e-05	0.000205	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—NDUFA13—thyroid cancer	1.2e-05	0.000205	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—HRAS—thyroid cancer	1.18e-05	0.000203	CbGpPWpGaD
Docetaxel—CYP3A4—Biological oxidations—RXRA—thyroid cancer	1.18e-05	0.000203	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TCF7L1—thyroid cancer	1.18e-05	0.000202	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.16e-05	0.000199	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—SLC5A5—thyroid cancer	1.16e-05	0.000199	CbGpPWpGaD
Docetaxel—EGFR—Disease—MEN1—thyroid cancer	1.16e-05	0.000199	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—NRAS—thyroid cancer	1.15e-05	0.000198	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—TP53—thyroid cancer	1.14e-05	0.000196	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—KRAS—thyroid cancer	1.14e-05	0.000196	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—SST—thyroid cancer	1.14e-05	0.000195	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—HRAS—thyroid cancer	1.13e-05	0.000194	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—CCND1—thyroid cancer	1.13e-05	0.000193	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—HRAS—thyroid cancer	1.12e-05	0.000193	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—HRAS—thyroid cancer	1.12e-05	0.000193	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CHST14—thyroid cancer	1.12e-05	0.000193	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—HRAS—thyroid cancer	1.12e-05	0.000192	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—HRAS—thyroid cancer	1.11e-05	0.000191	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	1.11e-05	0.000191	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	1.11e-05	0.000191	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—AKT1—thyroid cancer	1.11e-05	0.000191	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—thyroid cancer	1.1e-05	0.000189	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—TPR—thyroid cancer	1.09e-05	0.000188	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—PTEN—thyroid cancer	1.09e-05	0.000188	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.09e-05	0.000188	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CALCA—thyroid cancer	1.09e-05	0.000188	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—KRAS—thyroid cancer	1.09e-05	0.000188	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.09e-05	0.000186	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PRKAR1A—thyroid cancer	1.08e-05	0.000185	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—AKT1—thyroid cancer	1.06e-05	0.000182	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—TPR—thyroid cancer	1.06e-05	0.000182	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	1.06e-05	0.000181	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—PTEN—thyroid cancer	1.06e-05	0.000181	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	1.05e-05	0.000181	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—HRAS—thyroid cancer	1.05e-05	0.00018	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—HRAS—thyroid cancer	1.05e-05	0.00018	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—HRAS—thyroid cancer	1.05e-05	0.00018	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—AKT1—thyroid cancer	1.05e-05	0.00018	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PRKAR1A—thyroid cancer	1.04e-05	0.000179	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—HRAS—thyroid cancer	1.04e-05	0.000178	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.03e-05	0.000177	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—PPARG—thyroid cancer	1.03e-05	0.000177	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—HRAS—thyroid cancer	1.03e-05	0.000177	CbGpPWpGaD
Docetaxel—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	1.03e-05	0.000177	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—HRAS—thyroid cancer	1.02e-05	0.000176	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—AKT1—thyroid cancer	9.98e-06	0.000171	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—AKT1—thyroid cancer	9.93e-06	0.000171	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—AKT1—thyroid cancer	9.93e-06	0.000171	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—KRAS—thyroid cancer	9.93e-06	0.000171	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—HRAS—thyroid cancer	9.9e-06	0.00017	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CDK1—thyroid cancer	9.89e-06	0.00017	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—AKT1—thyroid cancer	9.88e-06	0.00017	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—AKT1—thyroid cancer	9.83e-06	0.000169	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—TP53—thyroid cancer	9.78e-06	0.000168	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CALCA—thyroid cancer	9.78e-06	0.000168	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—NRAS—thyroid cancer	9.76e-06	0.000168	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	9.76e-06	0.000168	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—RXRA—thyroid cancer	9.73e-06	0.000167	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—HRAS—thyroid cancer	9.7e-06	0.000167	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thyroid cancer	9.69e-06	0.000167	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—AKT1—thyroid cancer	9.65e-06	0.000166	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—TPR—thyroid cancer	9.63e-06	0.000165	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—TPR—thyroid cancer	9.54e-06	0.000164	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PRKAR1A—thyroid cancer	9.47e-06	0.000163	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.47e-06	0.000163	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	9.44e-06	0.000162	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—NRAS—thyroid cancer	9.41e-06	0.000162	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	9.39e-06	0.000161	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—thyroid cancer	9.28e-06	0.000159	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—AKT1—thyroid cancer	9.25e-06	0.000159	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—AKT1—thyroid cancer	9.25e-06	0.000159	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—AKT1—thyroid cancer	9.25e-06	0.000159	CbGpPWpGaD
Docetaxel—EGFR—Disease—CALCA—thyroid cancer	9.22e-06	0.000158	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—AKT1—thyroid cancer	9.17e-06	0.000158	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—AKT1—thyroid cancer	9.09e-06	0.000156	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—HPGD—thyroid cancer	9.06e-06	0.000156	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—AKT1—thyroid cancer	9.05e-06	0.000155	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CDK1—thyroid cancer	9.04e-06	0.000155	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	8.97e-06	0.000154	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CDK1—thyroid cancer	8.85e-06	0.000152	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—NRAS—thyroid cancer	8.83e-06	0.000152	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TP53—thyroid cancer	8.83e-06	0.000152	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	8.74e-06	0.00015	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—AKT1—thyroid cancer	8.74e-06	0.00015	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	8.71e-06	0.00015	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IFNA2—thyroid cancer	8.69e-06	0.000149	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—MINPP1—thyroid cancer	8.66e-06	0.000149	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TSHR—thyroid cancer	8.62e-06	0.000148	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—AKT1—thyroid cancer	8.56e-06	0.000147	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PRKAR1A—thyroid cancer	8.48e-06	0.000146	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—HRAS—thyroid cancer	8.44e-06	0.000145	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—KRAS—thyroid cancer	8.4e-06	0.000144	CbGpPWpGaD
Docetaxel—EGFR—Disease—CDK1—thyroid cancer	8.34e-06	0.000143	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8.32e-06	0.000143	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—AKT1—thyroid cancer	8.19e-06	0.000141	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—SLC5A5—thyroid cancer	8.19e-06	0.000141	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MEN1—thyroid cancer	8.11e-06	0.000139	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—TP53—thyroid cancer	8.1e-06	0.000139	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—KRAS—thyroid cancer	8.1e-06	0.000139	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—SLC5A5—thyroid cancer	7.92e-06	0.000136	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	7.9e-06	0.000136	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.67e-06	0.000132	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	7.62e-06	0.000131	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—KRAS—thyroid cancer	7.6e-06	0.000131	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—AKT1—thyroid cancer	7.45e-06	0.000128	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.42e-06	0.000128	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—TP53—thyroid cancer	7.41e-06	0.000127	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NDUFA13—thyroid cancer	7.37e-06	0.000127	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PTCH1—thyroid cancer	7.33e-06	0.000126	CbGpPWpGaD
Docetaxel—EGFR—Immune System—NRG1—thyroid cancer	7.25e-06	0.000125	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—SLC5A5—thyroid cancer	7.21e-06	0.000124	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—SLC5A5—thyroid cancer	7.14e-06	0.000123	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—HRAS—thyroid cancer	7.14e-06	0.000123	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NRG1—thyroid cancer	7.11e-06	0.000122	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.99e-06	0.00012	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CHST14—thyroid cancer	6.93e-06	0.000119	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—TPR—thyroid cancer	6.9e-06	0.000119	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—HRAS—thyroid cancer	6.89e-06	0.000118	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—RXRA—thyroid cancer	6.88e-06	0.000118	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	6.79e-06	0.000117	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SST—thyroid cancer	6.71e-06	0.000115	CbGpPWpGaD
Docetaxel—EGFR—Disease—NRG1—thyroid cancer	6.7e-06	0.000115	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.69e-06	0.000115	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—RXRA—thyroid cancer	6.66e-06	0.000114	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.47e-06	0.000111	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—HRAS—thyroid cancer	6.46e-06	0.000111	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CALCA—thyroid cancer	6.45e-06	0.000111	CbGpPWpGaD
Docetaxel—ABCC1—Disease—TERT—thyroid cancer	6.38e-06	0.00011	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—AKT1—thyroid cancer	6.3e-06	0.000108	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—NRAS—thyroid cancer	6.3e-06	0.000108	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—PTEN—thyroid cancer	6.24e-06	0.000107	CbGpPWpGaD
Docetaxel—BCL2—Immune System—PTEN—thyroid cancer	6.15e-06	0.000106	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PPARG—thyroid cancer	6.14e-06	0.000106	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HIF1A—thyroid cancer	6.1e-06	0.000105	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—AKT1—thyroid cancer	6.08e-06	0.000104	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—RXRA—thyroid cancer	6.05e-06	0.000104	CbGpPWpGaD
Docetaxel—EGFR—Disease—TERT—thyroid cancer	6.01e-06	0.000103	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—RXRA—thyroid cancer	6e-06	0.000103	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—PTEN—thyroid cancer	5.99e-06	0.000103	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	5.85e-06	0.000101	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CDK1—thyroid cancer	5.84e-06	0.0001	CbGpPWpGaD
Docetaxel—EGFR—Disease—HIF1A—thyroid cancer	5.75e-06	9.88e-05	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—AKT1—thyroid cancer	5.6e-06	9.62e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—HPGD—thyroid cancer	5.58e-06	9.59e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—NRAS—thyroid cancer	5.57e-06	9.56e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—NRAS—thyroid cancer	5.48e-06	9.42e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—KRAS—thyroid cancer	5.42e-06	9.32e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—NRAS—thyroid cancer	5.34e-06	9.18e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—TPR—thyroid cancer	5.2e-06	8.94e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	5.2e-06	8.94e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—SLC5A5—thyroid cancer	5.16e-06	8.87e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PRKAR1A—thyroid cancer	5.12e-06	8.8e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—BRAF—thyroid cancer	5.05e-06	8.68e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PTGS2—thyroid cancer	4.83e-06	8.31e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—KRAS—thyroid cancer	4.79e-06	8.23e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—BRAF—thyroid cancer	4.76e-06	8.18e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—KRAS—thyroid cancer	4.72e-06	8.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NRG1—thyroid cancer	4.69e-06	8.06e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—HRAS—thyroid cancer	4.61e-06	7.92e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—KRAS—thyroid cancer	4.6e-06	7.9e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	4.39e-06	7.55e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PPARG—thyroid cancer	4.34e-06	7.46e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—RXRA—thyroid cancer	4.34e-06	7.45e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PTEN—thyroid cancer	4.22e-06	7.24e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TERT—thyroid cancer	4.21e-06	7.23e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PPARG—thyroid cancer	4.2e-06	7.22e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTGS2—thyroid cancer	4.08e-06	7.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—HRAS—thyroid cancer	4.07e-06	7e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—AKT1—thyroid cancer	4.07e-06	6.99e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HIF1A—thyroid cancer	4.03e-06	6.92e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HRAS—thyroid cancer	4.01e-06	6.89e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HRAS—thyroid cancer	3.91e-06	6.72e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SLC5A5—thyroid cancer	3.9e-06	6.69e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTGS2—thyroid cancer	3.85e-06	6.61e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PPARG—thyroid cancer	3.82e-06	6.57e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PPARG—thyroid cancer	3.79e-06	6.51e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PTEN—thyroid cancer	3.63e-06	6.24e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—AKT1—thyroid cancer	3.59e-06	6.18e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTEN—thyroid cancer	3.56e-06	6.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—NRAS—thyroid cancer	3.55e-06	6.1e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—AKT1—thyroid cancer	3.54e-06	6.09e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—AKT1—thyroid cancer	3.45e-06	5.93e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTGS2—thyroid cancer	3.42e-06	5.87e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTEN—thyroid cancer	3.35e-06	5.76e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—BRAF—thyroid cancer	3.33e-06	5.73e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTGS2—thyroid cancer	3.31e-06	5.68e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—RXRA—thyroid cancer	3.27e-06	5.62e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—NRAS—thyroid cancer	3.24e-06	5.57e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—TPR—thyroid cancer	3.21e-06	5.51e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NRAS—thyroid cancer	3.18e-06	5.46e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	3.15e-06	5.42e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—KRAS—thyroid cancer	3.05e-06	5.25e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTGS2—thyroid cancer	3.01e-06	5.17e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—NRAS—thyroid cancer	2.99e-06	5.14e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTGS2—thyroid cancer	2.98e-06	5.12e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTEN—thyroid cancer	2.98e-06	5.12e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTEN—thyroid cancer	2.88e-06	4.95e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—KRAS—thyroid cancer	2.79e-06	4.79e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PPARG—thyroid cancer	2.74e-06	4.71e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—KRAS—thyroid cancer	2.73e-06	4.7e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTEN—thyroid cancer	2.62e-06	4.51e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTEN—thyroid cancer	2.6e-06	4.47e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HRAS—thyroid cancer	2.6e-06	4.46e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—KRAS—thyroid cancer	2.58e-06	4.43e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCND1—thyroid cancer	2.43e-06	4.18e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—AKT1—thyroid cancer	2.43e-06	4.17e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SLC5A5—thyroid cancer	2.4e-06	4.12e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HRAS—thyroid cancer	2.37e-06	4.07e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PTEN—thyroid cancer	2.35e-06	4.04e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HRAS—thyroid cancer	2.32e-06	3.99e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—AKT1—thyroid cancer	2.29e-06	3.94e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—HRAS—thyroid cancer	2.19e-06	3.76e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTGS2—thyroid cancer	2.15e-06	3.7e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NRAS—thyroid cancer	2.1e-06	3.6e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—AKT1—thyroid cancer	2.09e-06	3.6e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PPARG—thyroid cancer	2.07e-06	3.55e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—AKT1—thyroid cancer	2.05e-06	3.52e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—RXRA—thyroid cancer	2.02e-06	3.47e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—AKT1—thyroid cancer	1.93e-06	3.32e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTEN—thyroid cancer	1.88e-06	3.23e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KRAS—thyroid cancer	1.8e-06	3.1e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—AKT1—thyroid cancer	1.72e-06	2.95e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—AKT1—thyroid cancer	1.66e-06	2.85e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTGS2—thyroid cancer	1.63e-06	2.79e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TP53—thyroid cancer	1.6e-06	2.75e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HRAS—thyroid cancer	1.53e-06	2.63e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—AKT1—thyroid cancer	1.51e-06	2.6e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—AKT1—thyroid cancer	1.5e-06	2.57e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTEN—thyroid cancer	1.42e-06	2.44e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AKT1—thyroid cancer	1.35e-06	2.33e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PPARG—thyroid cancer	1.27e-06	2.19e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—AKT1—thyroid cancer	1.08e-06	1.86e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTGS2—thyroid cancer	1e-06	1.72e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTEN—thyroid cancer	8.74e-07	1.5e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AKT1—thyroid cancer	8.17e-07	1.4e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AKT1—thyroid cancer	5.03e-07	8.65e-06	CbGpPWpGaD
